Vanguard Group Inc. Increases Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

Vanguard Group Inc. lifted its position in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,633,720 shares of the company’s stock after acquiring an additional 33,539 shares during the quarter. Vanguard Group Inc. owned 9.72% of Shockwave Medical worth $692,442,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Covestor Ltd boosted its stake in shares of Shockwave Medical by 484.9% during the 3rd quarter. Covestor Ltd now owns 427 shares of the company’s stock worth $85,000 after acquiring an additional 354 shares in the last quarter. International Assets Investment Management LLC lifted its stake in Shockwave Medical by 18,122.1% in the 4th quarter. International Assets Investment Management LLC now owns 141,586 shares of the company’s stock valued at $26,981,000 after buying an additional 140,809 shares in the last quarter. Edmond DE Rothschild Holding S.A. purchased a new stake in Shockwave Medical in the 4th quarter valued at approximately $6,683,000. Massachusetts Financial Services Co. MA lifted its stake in Shockwave Medical by 29.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 224,589 shares of the company’s stock valued at $42,798,000 after buying an additional 50,478 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in Shockwave Medical by 109.0% in the 3rd quarter. American Century Companies Inc. now owns 170,866 shares of the company’s stock valued at $34,019,000 after buying an additional 89,094 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Shockwave Medical Trading Down 0.0 %

SWAV stock opened at $334.75 on Monday. The company has a market cap of $12.57 billion, a price-to-earnings ratio of 78.21, a PEG ratio of 2.43 and a beta of 0.88. The company has a quick ratio of 12.61, a current ratio of 13.81 and a debt-to-equity ratio of 0.97. The business has a fifty day simple moving average of $331.90 and a 200-day simple moving average of $274.53. Shockwave Medical, Inc. has a 52 week low of $157.00 and a 52 week high of $334.90.

Shockwave Medical (NASDAQ:SWAV) last released its quarterly earnings data on Monday, May 6th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. The business had revenue of $218.80 million during the quarter, compared to the consensus estimate of $207.69 million. Shockwave Medical had a return on equity of 24.79% and a net margin of 20.75%. The business’s revenue for the quarter was up 35.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.03 EPS. On average, equities research analysts expect that Shockwave Medical, Inc. will post 5.05 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on SWAV shares. Morgan Stanley reaffirmed an “equal weight” rating and issued a $335.00 target price (up previously from $285.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $335.00 target price (up previously from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Needham & Company LLC reiterated a “hold” rating on shares of Shockwave Medical in a report on Friday, April 5th. CL King reiterated a “neutral” rating on shares of Shockwave Medical in a report on Monday, April 8th. Finally, Canaccord Genuity Group reiterated a “hold” rating and issued a $335.00 price target (up from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. Ten analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $309.11.

Insider Activity at Shockwave Medical

In related news, insider Isaac Zacharias sold 4,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total value of $1,150,680.00. Following the completion of the sale, the insider now directly owns 56,818 shares in the company, valued at approximately $16,344,834.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Laura Francis sold 1,500 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total value of $450,000.00. Following the completion of the sale, the director now directly owns 3,551 shares in the company, valued at approximately $1,065,300. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the transaction, the insider now directly owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The disclosure for this sale can be found here. 3.40% of the stock is owned by insiders.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.